BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 5807434)

  • 1. [Iron and copper metabolism in hemochromatosis and Wilson's disease. Studies on relatives of patients].
    Petera V; Lahn V; Virt S; Voleníková L; Kohout J
    Z Gesamte Inn Med; 1969 May; 24(10):315-9. PubMed ID: 5807434
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis.
    Nair J; Carmichael PL; Fernando RC; Phillips DH; Strain AJ; Bartsch H
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):435-40. PubMed ID: 9610794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presymptomatic Wilson's disease. Diagnosis, therapy and family examination].
    Schmid-Rüter E; Feist D; Wesch H; Rossner JA; Schärer K
    Dtsch Med Wochenschr; 1973 Sep; 98(37):1698-703. PubMed ID: 4125854
    [No Abstract]   [Full Text] [Related]  

  • 4. Iron accumulation in the liver of male patients with Wilson's disease.
    Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
    Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference limits for copper and iron in liver biopsies.
    Nuttall KL; Palaty J; Lockitch G
    Ann Clin Lab Sci; 2003; 33(4):443-50. PubMed ID: 14584759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups.
    Walshe JM; Potter G
    Q J Med; 1977 Oct; 46(184):445-62. PubMed ID: 413153
    [No Abstract]   [Full Text] [Related]  

  • 9. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 10. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Wilson's disease in asymptomatic patients.
    Sternlieb I; Scheinberg IH
    N Engl J Med; 1968 Feb; 278(7):352-9. PubMed ID: 5635646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of the iron and copper content of the liver for the differential diagnosis of chronic liver diseases].
    Schwabe U; Friedrich K
    Z Gastroenterol; 1990 Jul; 28(7):353-7. PubMed ID: 2238766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of bulky DNA lesions in the liver of patients with Wilson's disease and primary haemochromatosis.
    Carmichael PL; Hewer A; Osborne MR; Strain AJ; Phillips DH
    Mutat Res; 1995 Feb; 326(2):235-43. PubMed ID: 7529889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening asymptomatic family members for Wilson's disease.
    Lindahl JA; Sharp HL
    Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
    [No Abstract]   [Full Text] [Related]  

  • 15. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the content of several microelements (copper, iron, zinc, manganese and molybdenum) in the blood and urine in hepato-cerebral dystrophy].
    Loĭko EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):188-92. PubMed ID: 5655734
    [No Abstract]   [Full Text] [Related]  

  • 17. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
    Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
    J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metals and the liver: receptacles to receptors and recombinant DNA.
    Powell LW
    Semin Liver Dis; 1984 Aug; 4(3):iii-vii. PubMed ID: 6091276
    [No Abstract]   [Full Text] [Related]  

  • 19. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B; el-Kamel M
    Tunis Med; 1974; 52(1):29-31. PubMed ID: 4215182
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.